P990045S007

None

FDA Premarket Approval P990045 S007

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP990045S007
Classification NameNone
Applicant
PMAP990045
SupplementS007

Supplemental Filings

Supplement NumberDateSupplement Type
P990045Original Filing
S029 2021-11-23 30-day Notice
S028 2020-07-16 30-day Notice
S027 2019-08-28 30-day Notice
S026 2019-06-18 30-day Notice
S025 2018-05-30 30-day Notice
S024 2018-03-30 30-day Notice
S023
S022 2018-02-14 30-day Notice
S021 2017-09-18 30-day Notice
S020 2017-04-25 30-day Notice
S019 2017-03-29 30-day Notice
S018 2016-05-10 30-day Notice
S017 2014-06-05 30-day Notice
S016 2013-12-27 30-day Notice
S015 2013-06-05 30-day Notice
S014 2012-11-09 Special (immediate Track)
S013
S012 2012-02-17 30-day Notice
S011 2011-10-18 30-day Notice
S010 2009-11-13 135 Review Track For 30-day Notice
S009 2009-11-13 Real-time Process
S008 2005-08-03 30-day Notice
S007
S006 2004-04-05 30-day Notice
S005 2003-10-20 Real-time Process
S004 2003-04-07 Normal 180 Day Track No User Fee
S003 2002-10-17 30-day Notice
S002 2002-01-18 Normal 180 Day Track
S001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.